In a clinical trial, people on tirzepatide experienced an average of 15% weight loss on 5 mg, 19% on 10 mg, and 21% on 15 mg
Yuval Pinto, an obesity medicine physician at Johns Hopkins Medicine, tells Outside
IGF-1 LR3 represents a well-characterised, research-grade analogue of human IGF-1, providing an extended-acting model for the study of growth-factor-mediated signalling
It also covers the extent of weight expected to be regained on cessation of treatment
"The drink drive limit"
Many of the ingredients found in these supplements, such as fiber, green tea extract, and berberine, are generally considered safe when taken at recommended doses, says Dr